BNB has been highly volatile recently, hitting an all-time high of $855 on Monday before undergoing a correction. Currently, it's battling to hold key support levels around $800, after dipping from its peak. This surge was fueled by significant institutional interest, including Windtree Therapeutics' $520 million commitment to build a BNB corporate treasury.
While the momentum indicators suggest an overbought condition, the overall sentiment remains bullish, with analysts eyeing further gains towards $900 if current support holds. Daily transaction volumes and open interest in derivatives have also seen a substantial increase, indicating strong trader activity and confidence in BNB's ecosystem growth.
